Efficacy and safety of hepatic artery infusion chemotherapy combined with tyrosine kinase inhibitors plus programmed death-1 inhibitors for hepatocellular carcinoma refractory to transarterial chemoembolization

BACKGROUND: The subsequent therapy for hepatocellular carcinoma (HCC) patients with refractory to transarterial chemoembolization (TACE) is still controversial. This study was performed to evaluate the efficacy and safety of combination therapy comprising hepatic artery infusion chemotherapy (HAIC),...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Long-Wang, Ke, Kun, Yan, Le-Ye, Chen, Rong, Huang, Jing-Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189040/
https://www.ncbi.nlm.nih.gov/pubmed/37207144
http://dx.doi.org/10.3389/fonc.2023.1178428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189040/
https://www.ncbi.nlm.nih.gov/pubmed/37207144
http://dx.doi.org/10.3389/fonc.2023.1178428

Ejemplares similares